ZIM (ZIM)

$3.2B
Market Cap
6.6
P/E Ratio
1.45
Beta
7.60%
Dividend Yield
Piotroski 4/9Altman Z 1.5 DistressBeneish M -3.17 CleanROIC−WACC -3.5%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 1.5.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency appears strained, evidenced by a negative ROIC-WACC spread of -3.5%, indicating the firm is currently destroying value relative to its cost of equity despite reporting an elevated DuPont ROE of 53.1%. This high return on equity is driven primarily by significant leverage (Equity Multiplier at 2.82x) and robust net margins (6.9% reported, though a conflicting 25.5% figure appears in the decomposition data), rather than operational efficiency or asset turnover. While the Beneish M-Score of -3.17 suggests low earnings manipulation risk, the Altman Z-Score of 1.5 signals elevated bankruptcy risk, compounded by a deteriorating Piotroski F-Score of 4/9 and a sharp contraction in revenue growth to -18.1% year-over-year. These fundamentals collectively point to an operation facing severe headwinds that have eroded the quality of its earnings generation.

Valuation metrics present a stark divergence between current pricing and modeled intrinsic value, with shares trading at 6.6x P/E versus a DCF-derived fair value of $395 per share. This substantial gap implies the market is aggressively discounting future cash flows, likely pricing in a prolonged period of negative growth or potential distress given the weak revenue trajectory and precarious solvency indicators. The low multiple does not necessarily reflect an undervalued opportunity; rather, it may be a rational reflection of the high cost of capital required to fund operations that are currently failing to generate returns above the WACC threshold.

The risk-reward profile is heavily skewed toward downside volatility due to the combination of negative spread economics and distress signals from credit metrics. While the low P/E offers limited immediate buffer against further deterioration, the fundamental drivers—shrinking revenues and high leverage—are structural concerns that could prevent any meaningful recovery in near-term earnings quality without a significant shift in operational dynamics or capital structure.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.6%13.6%15.6%
2%$455$369$310
3%$496$395$327
4%$548$426$347

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.6%, terminal growth 3%. Fair value $395 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
1.5
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.17
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

19.1%
Gross Margin
6.9%
Net Margin
10.1%
ROIC
13.6%
WACC
ROIC − WACC Spread: -3.5%— Negative spread.
-18.1%
Revenue Growth (YoY)
-77.7%
Earnings Growth (YoY)
2.1B
Free Cash Flow
25%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

25.5%
Net Profit Margin
NI ÷ Revenue
×
0.74x
Asset Turnover
Revenue ÷ Assets
×
2.82x
Equity Multiplier
Assets ÷ Equity
=
53.1%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

1.73x
Debt / Equity
1.23x
Current Ratio
2.4x
Interest Coverage
-0.4x
Net Debt / EBITDA
97.32%
FCF Yield
2.4B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.96
Act: $2.44
+24.2%
Q3
✗ Miss
Est: $1.30
Act: $0.19
-85.4%
Q2
✗ Miss
Est: $1.06
Act: $1.03
-3.0%
Q1
✓ Beat
Est: $-0.62
Act: $-0.42
+32.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

-5.9
Forward P/E
PEG Ratio
0.78
Price/Book
4M
Avg Volume
$29.97
52W High
$11.04
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in ZIM to visualize passive redemption contagion across ETFs and collateral stocks.

ZIM Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ZIMEpicenterSPDWETFGWXETFSMSNUnknownA000660UnknownASMLLow RiskHSBAUnknownROPMed Risk
ZIM Price Drop (%)0

If ZIM (ZIM) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies SAMSUNG ELECTR GDR REG S (SMSN) as the most exposed collateral stock, sharing 1 ETFs with ZIM. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

ZIM Ownership Dynamics

Ticker
ZIM

ETFs with Highest ZIM Exposure

Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

ZIM Capital Efficiency

How efficiently does ZIM convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$2.1B
EBITDA
$2.4B
FCF Conversion
86%
Reinvestment Rate
14%
86% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
10.1%
ROIC − WACC Spread
-3.5%

ZIM converts 86% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-3.5%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0825,164$26.09$656,528.76
2026-05-07161,810$27.84$4.5M
2026-05-065$28.55$142.75
2026-04-201,600$27.01$43,216
2026-03-312,035$25.88$52,665.8
2026-03-302,779$26.19$72,782.01
2026-03-275,098$26.25$133,822.5
2026-03-262,370$26.44$62,662.8
2026-03-251,964$26.46$51,967.44
2026-03-23332,686$25.88$8.6M
2026-03-2034,684$26.96$935,080.64
2026-03-19160,105$27.14$4.3M
2026-03-181,644$27.41$45,062.04
2026-03-17284$26.72$7,588.48
2026-03-13107$27.20$2,910.4
2026-03-124,233$28.07$118,820.31
2026-03-113,911$28.92$113,106.12
2026-03-10409$29.11$11,905.99
2026-03-09463$27.81$12,876.03
2026-03-046,348$27.91$177,172.68
2026-03-032,327$28.83$67,087.41
2026-03-028,265$28.83$238,279.95
2026-02-275,328$28.86$153,766.08
2026-02-2584,352$29.08$2.5M
2026-02-2452,428$28.66$1.5M
2026-02-2370,193$29.27$2.1M
2026-02-2063,296$29.18$1.8M
2026-02-1947,014$29.03$1.4M
2026-02-1860,791$27.85$1.7M
2026-02-1713,387$22.20$297,191.4

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare ZIM to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.